A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Arvinas Inc.
Arvinas Inc.
NeoTX Therapeutics Ltd.
University of Pittsburgh
University of Pittsburgh
Inhibrx Biosciences, Inc
Delcath Systems Inc.
National Cancer Institute (NCI)